The company, which manufactures intermediate chemicals and active pharmaceutical ingredients (API) commenced production in April 2019 with an investment of Rs 200 crore.
The company, which manufactures intermediate chemicals and active pharmaceutical ingredients (API) commenced production in April 2019 with an investment of Rs 200 crore.